- Home
- PEBO vs IMTX Comparison
PEBO vs IMTX Comparison
Compare PEBO & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEBO | IMTX |
|---|---|---|
| Founded | 1902 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | PEBO | IMTX |
|---|---|---|
| Price | $39.32 | $9.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $37.33 | $19.00 |
| AVG Volume (30 Days) | 260.2K | ★ 345.9K |
| Earning Date | 04-21-2026 | 05-13-2026 |
| Dividend Yield | ★ 4.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $197,000.00 | N/A |
| Revenue This Year | $17.29 | N/A |
| Revenue Next Year | $2.97 | $25.91 |
| P/E Ratio | $49.38 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.49 | $5.05 |
| 52 Week High | $40.19 | $12.41 |
Technical Indicators
Market Signals| Indicator | PEBO | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 64.76 | 47.43 |
| Support Level | $33.72 | $8.98 |
| Resistance Level | N/A | $10.67 |
| Average True Range (ATR) | 0.72 | 0.53 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 71.99 | 30.79 |
Price Performance
Historical ComparisonAbout PEBO Peoples Bancorp Inc.
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.